Flavoxate hydrochloride
- CAS No.
- 3717-88-2
- Chemical Name:
- Flavoxate hydrochloride
- Synonyms
- DW-61;Urispas;genurin;spasuret;bladderon;nsc-114649;REC-7-0040;FLAVOXATE HCL;FLAVOMYCINPREMIX;flaroxatehydrochloride
- CBNumber:
- CB4243322
- Molecular Formula:
- C24H26ClNO4
- Molecular Weight:
- 427.92
- MOL File:
- 3717-88-2.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/24 17:31:20
| Melting point | 232-234°C |
|---|---|
| storage temp. | Inert atmosphere,Room Temperature |
| solubility | H2O: ~6.6 mg/mL |
| form | solid |
| color | white |
| InChI | InChI=1S/C24H25NO4.ClH/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25;/h2,4-5,8-12H,3,6-7,13-16H2,1H3;1H |
| InChIKey | XOEVKNFZUQEERE-UHFFFAOYSA-N |
| SMILES | C12OC(=C(C)C(=O)C=1C=CC=C2C(=O)OCCN1CCCCC1)C1C=CC=CC=1.Cl |
| CAS DataBase Reference | 3717-88-2(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H335 | |||||||||
| Precautionary statements | P301+P312+P330 | |||||||||
| Hazard Codes | Xn | |||||||||
| Risk Statements | 22-36/37/38 | |||||||||
| Safety Statements | 26 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | DJ2450000 | |||||||||
| HS Code | 29349990 | |||||||||
| Toxicity | LD50 i.v. in rats: 27.4 mg/kg (Cazzulani) | |||||||||
| NFPA 704 |
|
Flavoxate hydrochloride price More Price(3)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich(India) | PHR3316 | Flavoxate hydrochloride certified reference material, pharmaceutical secondary standard | 3717-88-2 | 500MG | ₹18586.53 | 2022-06-14 | Buy |
| TCI Chemicals (India) | F0717 | Flavoxate Hydrochloride | 3717-88-2 | 5G | ₹6900 | 2022-05-26 | Buy |
| TCI Chemicals (India) | F0717 | Flavoxate Hydrochloride | 3717-88-2 | 25G | ₹14200 | 2022-05-26 | Buy |
Flavoxate hydrochloride Chemical Properties,Uses,Production
Chemical Properties
Flavoxate hydrochloride is Crystalline Solid
Definition
ChEBI: The hydrochloride salt of flavoxate.
Side effects
The following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency.
Gastrointestinal: Nausea, vomiting, dry mouth.
CNS: Vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness.
Hematologic: Leukopenia (one case which was reversible upon discontinuation of the drug).
Cardiovascular: Tachycardia and palpitation.
Allergic: Urticaria and other dermatoses, eosinophilia and hyperpyrexia.
Ophthalmic: Increased ocular tension, blurred vision, disturbance in eye accommodation.
Renal: Dysuria.
Pharmacology
Flavoxate hydrochloride counteracts smooth muscle spasm of the urinary tract and exerts its effect directly on the muscle. In a single study of 11 normal male subjects, the time to onset of action was 55 minutes. The peak effect was observed at 112 minutes. 57% of the flavoxate hydrochloride was excreted in the urine within 24 hours.
Flavoxate hydrochloride Preparation Products And Raw materials
Raw materials
chevron_left
1of2
chevron_rightPreparation Products
Global( 334)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Ralington Pharma | +91-7948911722 +91-9687771722 | Gujarat, India | 1350 | 58 | Inquiry |
| Ami Lifesciences Pvt Ltd | +91-9426998100 +91-9426998100 | Gujarat, India | 62 | 58 | Inquiry |
| Bioaltus Laboratories Pvt Ltd | +91-2249744539 +91-9820139885 | Maharashtra, India | 34 | 58 | Inquiry |
| Ar Ex Laboratories Pvt Ltd | 91-22-24454109 | Maharashtra, India | 18 | 58 | Inquiry |
| Bioxera Pharma Pvt. Ltd. | +91-2261842739 +91-2266862739 | Maharashtra, India | 20 | 58 | Inquiry |
| Meruvax Pharma (South Asia) | +91 917-735-9925 | Andhra Pradesh, India | 106 | 58 | Inquiry |
| Ralington Pharma. | 91-79-48911722 | Gujarat, India | 311 | 58 | Inquiry |
| Dazzle Corporation | 91-22-28878459 | Maharashtra, India | 209 | 58 | Inquiry |
| Mesha Pharma Private Limited | 08048372569Ext 806 | Mumbai, India | 133 | 58 | Inquiry |
| Viraj Pharmaceuticals Pvt. Ltd. | 91-22-25008829 | Maharashtra, India | 162 | 58 | Inquiry |
3717-88-2(Flavoxate hydrochloride)Related Search:
chevron_left
1of4
chevron_right
FLAVOMYCINPREMIX
1-piperidineethanol,3-methyl-4-oxo-2-phenyl-4h-1-benzopyran-8-carboxylate,h
2-piperidinoethyl-3-methyl-4-oxo-2-phenyl-4h-1-benzopyran-8-carboxylatehydro
3-methyl-4-oxo-2-phenyl-4h-1-benzopyran-8-carboxylicaci2-piperidinoethyl
bladderon
Urispas
Flavoxate hydrochloride,3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester hydrochloride, DW-61, Rec-7-0040
Flavoxate Hydrochloride (200 mg)
4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester, hydrochloride (1:1)
Flavoxate Hydrochloride Imp. (EP)
2-(Piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride
flaroxatehydrochloride
genurin
nsc-114649
piperidinoethyl-3-methylflavone-8-carboxylatehydrochloride
spasuret
REC-7-0040
FLAVOXATE HCL
FLAVOXATE HYDROCHLORIDE
DW-61
3-METHYL-4-OXO-2-PHENYL-4H-1-BENZOPYRAN-8-CARBOXYLIC ACID 2-(1-PIPERIDINYL)ETHYL ESTER HYDROCHLORIDE
3-METHYL-4-OXO-2-PHENYL-4H-BENZOPYRAN-8-CARBOXYLIC ACID 2-PIPERIDINYL ETHYL ESTER HYDROCHLORIDE
Flavoxate hydrochloride, 99%, a muscarinic AChR antagonist
3-methyl-4-oxo-2-phenyl-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester
Flavoxate hydrochloride CRS
Flavoxate hydrochloride USP/EP/BP
Flavoxate HCl (Rec-7-0040
flavonoid hydrochloride
Flavoxate HydrochlorideQ: What is
Flavoxate Hydrochloride Q: What is the CAS Number of
Flavoxate Hydrochloride Q: What is the storage condition of
Flavoxate Hydrochloride Q: What are the applications of
Flavoxate Hydrochloride
Flavoxate Hydrochloride (1270708)
Flavoxate HCl|||NSC-114649|||DW61|||Rec-7-0040
3717-88-2
C24H25NO4HCl
C24H25NO4HClC24H26ClNO4
C24H25NO4ClH
Voltage-gated Ion Channels
Inhibitors and Activators
Ion Channels
Cell Biology
Calcium Channel Modulators
Cell Signaling and Neuroscience
BioChemical
Aromatics
Heterocycles
Intermediates & Fine Chemicals
Pharmaceuticals
ACTIVE PHARMACEUTICAL INGREDIENTS
API